181 results
Page 3 of 10
6-K
EX-99.1
ar9his b4wq
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.2
658xcra1 rmg0ruirhl
29 Aug 22
Current report (foreign)
4:00pm
6-K
EX-99.1
9eugn2v7g
29 Aug 22
Current report (foreign)
4:00pm
6-K
0eynwkqkgff0 9vqa
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-2.1
e2a48m8o
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-10.4
xlt4rstff3hfj0kg9ji
8 Jul 22
Current report (foreign)
8:58am
6-K
2o518af5b tzjqgif3
8 Jul 22
Current report (foreign)
8:58am
6-K
lfynj
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
20-F/A
423avv
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.2
jjfzs4cbfo476p1
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.1
muf62plovit
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
8vysjk3kiozq
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
47aeet j8jqlikf4
30 Aug 21
Current report (foreign)
5:21pm